U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07343076) titled 'Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTEMI and Multivessel Disease (FUTURE II)' on Jan. 06.

Brief Summary: This is a prospective, multi-center, randomized controlled, open-label, blinded endpoint assessment study. The objective is to compare the efficacy of immediate complete revascularization versus staged complete revascularization strategies in non-ST-segment elevation myocardial infarction (NSTEMI) patients with multivessel disease.

NSTEMI patients who have successfully undergone PCI of culprit vessel will be judged based on the angiography results whether they meet the definition of ...